Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
破解密碼：了解Intellia Therapeutics的分析師評論
In the last three months, 4 analysts have published ratings on Intellia Therapeutics (NASDAQ:NTLA), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中，4名分析師對Intellia Therapeutics（NASDAQ:NTLA）進行了評級，提供了從看好到看淡的不同視角。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Intellia Therapeutics, presenting an average target of $48.25, a high estimate of $70.00, and a low estimate of $29.00. A decline of 8.39% from the prior average price target is evident in the current average.
在12個月的價格目標評估中，分析師揭示了有關Intellia Therapeutics的見解，呈現出平均目標48.25美元，高估70.00美元，低估29.00美元。當前平均價格目標較前一個平均目標下降了8.39%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
A comprehensive examination of...
最近的分...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。